PQIA Stock Overview Provides outpatient diagnostic imaging services in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add notePrice History & Performance
Summary of share price highs, lows and changes for RadNet Historical stock prices Current Share Price US$68.00 52 Week High US$84.00 52 Week Low US$30.60 Beta 1.77 1 Month Change -11.69% 3 Month Change 9.68% 1 Year Change 113.84% 3 Year Change 153.73% 5 Year Change 279.89% Change since IPO 4,567.12%
Recent News & Updates
Third quarter 2024 earnings released: EPS: US$0.044 (vs US$0.26 in 3Q 2023) Nov 11
RadNet, Inc. Revises Earnings Guidance for the Year 2024 Nov 11
RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024 Sep 13
Insider recently sold €846k worth of stock Aug 23
Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023) Aug 08
New minor risk - Share price stability Aug 06 See more updates
Third quarter 2024 earnings released: EPS: US$0.044 (vs US$0.26 in 3Q 2023) Nov 11
RadNet, Inc. Revises Earnings Guidance for the Year 2024 Nov 11
RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024 Sep 13
Insider recently sold €846k worth of stock Aug 23
Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023) Aug 08
New minor risk - Share price stability Aug 06
Insufficient new directors Jul 01
Executive VP recently sold €930k worth of stock Jun 13
First quarter 2024 earnings released: US$0.04 loss per share (vs US$0.36 loss in 1Q 2023) May 09
RadNet, Inc., Annual General Meeting, Jun 12, 2024 Apr 28 RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.
Now 23% overvalued after recent price rise Mar 06
Full year 2023 earnings released: EPS: US$0.048 (vs US$0.19 in FY 2022) Mar 01
Insider recently sold €328k worth of stock Dec 08
RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering Dec 07
RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio Nov 29
RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio Nov 28
Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.012 in 3Q 2022) Nov 10
New major risk - Financial position Aug 10
RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer Aug 10
Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2022) Aug 09
Radnet, Inc. Revises Earnings Guidance for the Year 2023 Aug 09
RadNet, Inc. Announces Appointment of Executives Aug 02 RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million. Jun 15
President & COO of Western Operations recently sold €1.3m worth of stock Jun 12
RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors Jun 09
Board Member recently sold €128k worth of stock May 26
RadNet, Inc., Annual General Meeting, Jun 07, 2023 May 26
RadNet, Inc. Revises Earnings Guidance for the Year 2023 May 12
First quarter 2023 earnings released: US$0.36 loss per share (vs US$0.054 profit in 1Q 2022) May 12
President & COO of Eastern Operations recently sold €217k worth of stock Mar 19
Insider recently sold €418k worth of stock Mar 08
Full year 2022 earnings released: EPS: US$0.19 (vs US$0.47 in FY 2021) Mar 03
Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence Feb 07
President & COO of Western Operations recently sold €92k worth of stock Dec 21
Third quarter 2022 earnings released: EPS: US$0.012 (vs US$0.31 in 3Q 2021) Nov 11
RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022 Nov 10
RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited. Nov 02
Investor sentiment improved over the past week Sep 30
Investor sentiment improved over the past week Aug 17
Second quarter 2022 earnings released: EPS: US$0.14 (vs US$0.055 in 2Q 2021) Aug 11
RadNet, Inc. Updates Earnings Guidance for 2022 Aug 10
President & COO of Western Operations recently sold €193k worth of stock Jun 03
RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms May 18
First quarter 2022 earnings released: EPS: US$0.054 (vs US$0.18 in 1Q 2021) May 11 RadNet, Inc. Revises Earnings Guidance for the Fiscal Year 2022 May 10
RadNet, Inc., Annual General Meeting, Jun 08, 2022 May 02
RadNet, Inc. Provides Earnings Guidance for the Fiscal Year 2022 Mar 04
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Mar 03 RadNet, Inc. (NasdaqGM:RDNT) acquired Quantib B.V. for $45 million.
Third quarter 2021 earnings released: EPS US$0.31 (vs US$0.12 in 3Q 2020) Nov 10
Senior VP of Human Resources & Director recently sold €86k worth of stock Sep 04
Investor sentiment deteriorated over the past week Aug 16
Lead Independent Director recently bought €129k worth of stock Aug 14
Second quarter 2021 earnings released: EPS US$0.055 (vs US$0.21 loss in 2Q 2020) Aug 10
Senior VP of Human Resources & Director recently sold €388k worth of stock Jun 17
Independent Director Marvin Cadwell has left the company Jun 15
VP, Medical Director & Director John Crues has left the company Jun 15
Insider recently sold €404k worth of stock Jun 02
Independent Director recently bought €238k worth of stock May 19
First quarter 2021 earnings released: EPS US$0.18 (vs US$0.33 loss in 1Q 2020) May 12
RadNet, Inc. Revises Earnings Guidance for the Year 2021 May 11
Independent Director recently sold €397k worth of stock Mar 17
Full year 2020 earnings released: US$0.29 loss per share (vs US$0.30 profit in FY 2019) Mar 10
Revenue beats expectations Mar 10
New 90-day high: €19.90 Mar 10
RadNet and its Partner Dignity Health, Plaza Companies and Holualoa Companies Team Up to Redevelop Park Central Feb 11
New 90-day high: €17.00 Jan 07
President & COO of Western Operations recently sold €236k worth of stock Dec 03
Third quarter 2020 earnings released: EPS US$0.12 Nov 11
Revenue beats expectations Nov 11
New 90-day high: €15.80 Nov 11 Radnet Creates Operating Platform in Phoenix, Arizona Through New Joint Venture with Dignity Health/CommonSpirit Health
New 90-day low: €11.90 Sep 25
President & COO of Western Operations recently sold €262k worth of stock Sep 23
New 90-day low - €12.70 Aug 29
First half earnings released Aug 11 Shareholder Returns PQIA DE Healthcare DE Market 7D -9.9% -3.5% -2.6% 1Y 113.8% 15.6% 6.9%
See full shareholder returns
Return vs Market: PQIA exceeded the German Market which returned 7.1% over the past year.
Price Volatility Is PQIA's price volatile compared to industry and market? PQIA volatility PQIA Average Weekly Movement 7.7% Healthcare Industry Average Movement 4.7% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: PQIA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PQIA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Show more RadNet, Inc. Fundamentals Summary How do RadNet's earnings and revenue compare to its market cap? PQIA fundamental statistics Market cap €5.06b Earnings (TTM ) -€4.23m Revenue (TTM ) €1.70b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) PQIA income statement (TTM ) Revenue US$1.77b Cost of Revenue US$1.35b Gross Profit US$423.02m Other Expenses US$427.43m Earnings -US$4.41m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.06 Gross Margin 23.86% Net Profit Margin -0.25% Debt/Equity Ratio 91.1%
How did PQIA perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 04:50 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources RadNet, Inc. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Sarah James Barclays Andrew Mok Barclays Juan Molta B. Riley Securities, Inc.
Show 9 more analysts